New Age Spa Institute

DECEMBER 18, 2024

Also known as NASI , this private beauty school in Des Plaines, IL offers training programs for professional licensing in esthetics, massage therapy, makeup, and more. Certifications are targeted programs designed to enhance your knowledge and skills in specific areas of esthetics, cosmetology, or massage therapy.

Medical 52

Medical Esthetics Legal Continuing Education 52

The Dermatology Digest

FEBRUARY 18, 2025

Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN.

Dermatitis 36

Dermatitis Marketing Hospital Clinic 36

The Dermatology Digest

MARCH 5, 2025

This is a great milestone for our team, as we continue to examine the acne market, we believe there is still a high unmet need by patients for an acne product like XYNGARI, says Gerry Proehl, Dermatas Chairman, President, and Chief Executive Officer, in a news release.

Treatments 36

Treatments Rosacea Pores Office 36

New Age Spa Institute

NOVEMBER 20, 2024

Licenses like those for esthetics, cosmetology , and massage therapy give professionals the legal right to practice their craft and offer services to the public. Choosing Between Esthetics, Cosmetology & Massage Therapy One of the most common questions we hear is, “ What’s the difference between an esthetician and a cosmetologist?

Esthetics 52

Esthetics Therapy Continuing Education Continuous Education 52

The Dermatology Digest

FEBRUARY 14, 2024

In addition, the European Medicines Agency has also accepted the Marketing Authorization Applications for nemolizumab in prurigo nodularis and atopic dermatitis. The European Medicines Agency has also accepted Galderma’s Marketing Authorization Applications for nemolizumab in both prurigo nodularis and atopic dermatitis.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

Aesthetics Advisor

AUGUST 18, 2023

Key Points: A few studies show that NAD+ IV therapy can alleviate alcohol and drug addiction, as well as Parkinson’s disease, but no studies have examined its effects on aging. Oral administration of NAD+ boosting therapy is safer, more cost effective, and more consistently dosed than intravenous administartion.

Therapy 36

Therapy Injections Safety Clinic 36

The Dermatology Digest

FEBRUARY 8, 2024

Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. It has great efficacy and safety and is oral… [This means] no shot and no risk of anaphylaxis.”

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

The Dermatology Digest

JUNE 14, 2024

Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.

Dermatitis 36

Dermatitis Marketing Safety Innovations 36

Aesthetics Advisor

AUGUST 19, 2023

Nevertheless, PRP and exosome-related therapies are not yet established as standard treatments, given their relatively recent emergence. Because the human body is specially equipped to heal itself, and regenerative therapies tap into this powerful ability. Regenerative medicine is also becoming a buzzword in the medical community.

Therapy 36

Therapy Injections Treatments Medical 36

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

The Dermatology Digest

DECEMBER 13, 2024

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion and recommended granting marketing authorization for nemolizumab (Nemluvio. The positive CHMP opinion will now be sent to the European Commission for the adoption of a decision on an EU-wide marketing authorization.

Dermatitis 36

Dermatitis Safety Marketing Therapy 36

The Dermatology Digest

JULY 22, 2024

Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

Spa Executive

JULY 17, 2024

Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces. For instance, it can offer solutions for communities where nudity or physical touch might be less comfortable or culturally sensitive.

Technology 98

Technology Hospital Sustainability Innovations 98

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 36

Eczema Dermatitis Safety Therapy 36

The Dermatology Digest

MAY 23, 2024

The Company also announced that the European Commission granted marketing authorization for bimekizumab-bkzx for the treatment of active moderate-to-severe HS in adults with an inadequate response to conventional systemic HS therapy in April 2024. The primary endpoint in both trials was HiSCR50 at Week 16.

Sustainability 36

Sustainability Safety Clinic Medical 36

AAAMS

MAY 9, 2024

Nurses were first taught the importance of maintaining a clean and sterile environment, with safety being the top priority. Still, today, it includes a range of high-tech treatments such as laser therapies, chemical peels, micro-needling, and non-surgical body contouring techniques. Ethics and patient safety are non-negotiable.

Training 52

Training Ethics Technology Injections 52

Spa Executive

JUNE 28, 2024

Wellness retreats continue to proliferate across the country, offering travelers opportunities to rejuvenate through practices like yoga, meditation, spa treatments and alternative therapies. These therapies are offered in dedicated sound therapy spaces within the spa or wellness facility, or even integrated into the hydrotherapy area.

Sustainability 52

Sustainability Therapy Technology Medical 52

Aesthetic Advancements Institute (AAI)

OCTOBER 18, 2023

microneedling market has seen a consistent upward trajectory since 2020, translating to more informed and effective treatments by practitioners. With the influx of devices in the market, using only FDA-approved microneedling devices becomes paramount to ensure safety and credibility. With Acne being a prime concern, the U.S.

Scarring 36

Scarring Microneedling Treatments Collagen 36

The Dermatology Digest

JULY 10, 2024

The interleukin-13 blocker is indicated for the treatment of adult and adolescent patients (12 years and older with a body weight of at least 40 kg) with moderate to severe AD, who are candidates for systemic therapy. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

California Skincare Supply

SEPTEMBER 21, 2021

From microcurrent to nano channeling, LED light therapy and beyond, the facials of the future have arrived, and the demand for glow-boosting, gadget-powered, skincare treatments is increasing rapidly. This is critical to ensuring the quality of your professional equipment and the safety of your clientele. Go, Go Gadget Skincare!

Tools 52

Tools Esthetician Skincare Facials 52

California Skincare Supply

OCTOBER 14, 2021

After microdermabrasion, you may want to offer or include popular add-ons such as LED light therapy for boosting recovery time, or custom serums and a facial mask to enhance treatment benefits. Why I love it: Besides the exfoliation options, you have the benefit of the ultrasound and Cold therapy all in one device.

Microdermabrasion 52

Microdermabrasion Exfoliation Chemical Peels Dermabrasion 52

New Age Spa Institute

JUNE 13, 2024

Each state has its own requirements for training programs and licensing exams, so it’s important to check with the specific state board of esthetics, cosmetology, massage therapy, and nail technology for detailed regulations and any updates. Business Educations is included in all licensure and certification programs!

Continuing Education 52

Continuing Education Continuous Education Education Esthetics 52

The Dermatology Digest

SEPTEMBER 9, 2024

“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. .”

Portfolios 36

Portfolios Dermatology Injections Marketing 36

California Skincare Supply

SEPTEMBER 21, 2021

From microcurrent to nano channeling, LED light therapy and beyond, the facials of the future have arrived, and the demand for glow-boosting, gadget-powered, skincare treatments is increasing rapidly. This is critical to ensuring the quality of your professional equipment and the safety of your clientele. Go, Go Gadget Skincare!

Tools 52

Tools Esthetician Skincare Facials 52

New Age Spa Institute

OCTOBER 3, 2024

For those ready to dive deeper, our Eyelash Extension Certification course provides a comprehensive look into lash extension application, maintenance, and safety. We have esthetics, makeup, and massage therapy students from all over the Midwest for licensure and continuing education, including Wisconsin, Indiana, and Michigan!

Continuing Education 52

Continuing Education Continuous Education Lash Extensions Makeup 52

The Dermatology Digest

FEBRUARY 13, 2024

MediWound Ltd’s EscharEx bested market leader collagenase Santyl ointment in wound debridement, promotion of granulation tissue, and time to wound closure in patients with chronic venous leg ulcers (VLU). The safety profile and overall incidence of adverse wound reactions were comparable between arms. days for EscharEx vs. 76.0

Safety 36

Safety Marketing Office Clinic 36

AAAMS

APRIL 21, 2024

To ensure patient safety and achieve optimal results, healthcare professionals must be well-versed in the fundamental concepts of body contouring. Good course content covers not just the basics but also in-depth aspects of body contouring, including safety, different technologies used, and patient management.

Training 52

Training Technology Medical Safety 52

California Skincare Supply

OCTOBER 14, 2021

After microdermabrasion, you may want to offer or include popular add-ons such as LED light therapy for boosting recovery time, or custom serums and a facial mask to enhance treatment benefits. Your Go-To Marketing Tagline for Estheticians Ready for precision exfoliation? Book your Diamonderm Microdermabrasion facial with us ASAP!

Microdermabrasion 52

Microdermabrasion Exfoliation Chemical Peels Esthetician 52

The Dermatology Digest

AUGUST 13, 2024

Nemolizumab was granted Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024 by the U.S. The phase III OLYMPIA 1 and OLYMPIA 2 clinical trials evaluated the efficacy and safety of nemolizumab administered subcutaneously every four weeks in more than 500 patients with prurigo nodularis.

Dermatitis 36

Dermatitis Clinic Safety Dermatology 36

The Dermatology Digest

MARCH 11, 2024

In addition, the European Medicines Agency has also accepted the Marketing Authorization Applications for nemolizumab in prurigo nodularis and atopic dermatitis. No new safety signals were observed in this trial. The FDA has granted nemolizumab Priority Review for prurigo nodularis.

Dermatitis 36

Dermatitis Safety Eczema Dermatology 36

The Dermatology Digest

DECEMBER 15, 2023

Food and Drug Administration (FDA) has expanded the approval of tralokinumab-ldrm (Adbry, LEO Pharma Inc) to include kids aged 12-17 years with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.

Eczema 28

Eczema Dermatitis Safety Therapy 28

The Dermatology Digest

MAY 15, 2024

alone and no FDA approved therapies, common warts represent one of the largest unmet needs in all of dermatology. seeking Food and Drug Administration approval for the use of YCANTH for the treatment of common warts, but may also be utilized by Verrica to seek future marketing authorizations in territories outside the U.S.

Pharmaceutical 36

Pharmaceutical Clinic Sales Dermatology 36

Aesthetics Advisor

FEBRUARY 16, 2024

Is it advisable or not to supplement with antioxidant therapy during combined chemotherapy and radiation therapy? People who hold this view maintain that antioxidants may counter the harmful effects of oxidation in the malignant process and thereby increase the effects of drugs or radiation therapy to the benefit of the patient.

Therapy 36

Therapy Diet Hospital Treatments 36

The Beauty Brains

APRIL 1, 2019

As you can imagine, this would be a huge market if someone found something that actually worked. I can tell you, the solution is not going to come from a Multilevel marketing company. Facial cupping was no doubt inspired by the general practice of so called Cupping Therapy that is popular with the alternative medicine crowd.

Ingredients 52

Ingredients Pharmaceutical Facials Social Media 52

California Skincare Supply

NOVEMBER 10, 2022

For application of topical ingredients, most micropens can be combined with a product line that offers serums that were designed to be used with microchanneling and have been tested for safety. To help prepare you, here are a few quick FAQs you can include in your marketing.

Microneedling 52

Microneedling Scarring Wrinkles Tools 52

Aesthetics Advisor

JUNE 16, 2024

As with so many skin-care trends that have come before, this one is rooted in medicine — in this case, regenerative medicine, which is centered on developing and applying therapies to help the body heal itself. But the authors also noted that “further studies are needed to assess the long-term efficacy and safety of this technique.”

Injections 36

Injections Aromatherapy Ingredients Moisturization 36